首页> 外文期刊>Journal of cancer survivorship: research and practice >A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy
【24h】

A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy

机译:多奈哌齐治疗辅助化疗后1至5年自我报告的认知功能障碍的女性乳腺癌幸存者的研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Some breast cancer survivors report cognitive difficulties greater than 1 year after chemotherapy. Acetylcholinesterase inhibitors (AChEI) may improve cognitive impairment. We conducted a randomized, placebo-controlled, pilot study to assess the feasibility of using the AChEI, donepezil, to improve subjective and objective measures of cognitive function in breast cancer survivors.
机译:一些乳腺癌幸存者报告说化疗后一年以上出现认知困难。乙酰胆碱酯酶抑制剂(AChEI)可以改善认知障碍。我们进行了一项随机,安慰剂对照的先导研究,以评估使用AChEI,多奈哌齐改善乳腺癌幸存者认知功能的主观和客观指标的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号